Scientists Can Identify Schwann Cells Using Novel Bar Code Technique
Image by Markus Spiske from Pixabay

Scientists Can Identify Schwann Cells Using Novel Bar Code Technique

Scientists and researchers have long known how important glial cells are to the nervous system. Not only do these cells make up a majority of cells within the central nervous…

Continue Reading Scientists Can Identify Schwann Cells Using Novel Bar Code Technique
New Drug Application for Niemann-Pick Disease Type C Treatment Submitted Under Rolling Review
source: pixabay.com

New Drug Application for Niemann-Pick Disease Type C Treatment Submitted Under Rolling Review

According to a story from globenewswire.com, the biopharmaceutical company Orphazyme A/S has recently announced that it has submitted its New Drug Application (NDA) for its experimental treatment arimoclomol to the…

Continue Reading New Drug Application for Niemann-Pick Disease Type C Treatment Submitted Under Rolling Review
Arimoclomol Receives the Fast Track Designation for the Treatment of ALS
source: pixabay.com

Arimoclomol Receives the Fast Track Designation for the Treatment of ALS

CytRx Corporation has recently received the Fast Track designation for their ALS treatment, arimoclomol. This status was also given for the treatment of Niemann-Pick disease and sporadic Inclusion Body Myositis…

Continue Reading Arimoclomol Receives the Fast Track Designation for the Treatment of ALS
Exploring the Similar Pathology “Genetic Doppelgängers” ALS and SCA36
Thor_Deichmann / Pixabay

Exploring the Similar Pathology “Genetic Doppelgängers” ALS and SCA36

Recently, scientists from Emory University set out to discover whether there was any pathological link between spinocerebellar ataxia type 36 (SCA36) and amyotrophic lateral sclerosis and frontotemporal dementia (ALS/FTD). Both…

Continue Reading Exploring the Similar Pathology “Genetic Doppelgängers” ALS and SCA36
Could Biobots be the Key to Understanding ALS and other Neuromuscular Diseases?
source: pixabay.com

Could Biobots be the Key to Understanding ALS and other Neuromuscular Diseases?

  Biological robots, commonly known as biobots, mimic the actions of other organisms (e.g. jumping or swimming). Biobots are composed of artificial materials and also organic material. As published in…

Continue Reading Could Biobots be the Key to Understanding ALS and other Neuromuscular Diseases?
New Therapy for ALS and Other Neurodegenerative Diseases
geralt / Pixabay

New Therapy for ALS and Other Neurodegenerative Diseases

ProMIS Neurosciences is a biotechnology company that works specifically with antibody treatments, and they have recently developed intrabodies for the treatment of amyotrophic lateral sclerosis (ALS). This same therapy has…

Continue Reading New Therapy for ALS and Other Neurodegenerative Diseases

Seneca Biopharma Preparing for its Phase 3 Trial to Test NSI-566 for Amyotrophic Lateral Sclerosis

Seneca Biopharma, Germantown, Md., issued a press release announcing its recent meeting with the FDA to discuss elements of a final design and protocol for a Phase 3 trial investigating…

Continue Reading Seneca Biopharma Preparing for its Phase 3 Trial to Test NSI-566 for Amyotrophic Lateral Sclerosis
How Do Ventilators Work?: A Video Review During COVID-19
source: pixabay.com

How Do Ventilators Work?: A Video Review During COVID-19

  If you have read the news at all lately, you know that ventilators are a sought-after piece of medical equipment. With hospitals looking to treat mass amounts of patients…

Continue Reading How Do Ventilators Work?: A Video Review During COVID-19
Researchers Discover New Gene that Contributes to the Progression of ALS
source: pixabay.com

Researchers Discover New Gene that Contributes to the Progression of ALS

Researchers at Columbia University have discovered a new gene, TBK1, that is linked to the progression of amyotrophic lateral sclerosis (ALS). A lack of understanding of a rare disease hinders…

Continue Reading Researchers Discover New Gene that Contributes to the Progression of ALS

Study Highlights Need to Support Youth Acting as Amyotrophic Lateral Sclerosis Caregivers

A recent study, conducted my Melinda Kavanaugh from the University of Wisconsin, Milwaukee, examined the role of children who are acting as caregivers for those diagnosed with amyotrophic lateral sclerosis…

Continue Reading Study Highlights Need to Support Youth Acting as Amyotrophic Lateral Sclerosis Caregivers
Neurodegenerative-Neuromuscular Diseases and Airway Clearance Therapy
source: pixabay.com

Neurodegenerative-Neuromuscular Diseases and Airway Clearance Therapy

  Advances in medicine have been responsible for longer overall survival in patients with neurodegenerative-neuromuscular diseases. According to a recent report in RTMagazine, an increase in the number of patients…

Continue Reading Neurodegenerative-Neuromuscular Diseases and Airway Clearance Therapy

ICYMI: The FDA Grants Orphan Status to a New Combination Drug to Treat ALS 

  According to a recent article in ALS News Today, the FDA’s Orphan Status designation has been granted to NeuroSense Therapeutics for its drug, PrimeC, to treat ALS. PrimeC received the designation…

Continue Reading ICYMI: The FDA Grants Orphan Status to a New Combination Drug to Treat ALS 
Orphan Drug Designation and Two New Clinical Trials for ALS Treatment
source: pixabay.com

Orphan Drug Designation and Two New Clinical Trials for ALS Treatment

NeuroSense Therapeutics, a biotechnology company, is in the process of developing PrimeC. PrimeC was created for the treatment of amyotrophic lateral sclerosis (ALS), and it is meant to slow or…

Continue Reading Orphan Drug Designation and Two New Clinical Trials for ALS Treatment
He Didn’t Want to Miss his Daughter’s First Birthday, so he Campaigned for a Cure for ALS
source: pixabay.com

He Didn’t Want to Miss his Daughter’s First Birthday, so he Campaigned for a Cure for ALS

As originally reported in ArcaMax,  when you get a diagnosis for a terminal rare disease, a wave of emotions crashes over life. Brian Wallach emerged clutching 'hope.' In 2017, Brian,…

Continue Reading He Didn’t Want to Miss his Daughter’s First Birthday, so he Campaigned for a Cure for ALS
Phase 2 Trial for Amyotrophic Lateral Sclerosis has Completed Enrollment
source: pixabay.com

Phase 2 Trial for Amyotrophic Lateral Sclerosis has Completed Enrollment

FightMND is an Australian nonprofit organization dedicated to improving the lives of motor neurone disease patients through funding research for cures. They've successfully provided millions toward research initiatives and clinical…

Continue Reading Phase 2 Trial for Amyotrophic Lateral Sclerosis has Completed Enrollment
AI Therapeutics’ LAM-002 Shows Positive Results in Treating Follicular Lymphoma and Hope for ALS
source: pixabay.com

AI Therapeutics’ LAM-002 Shows Positive Results in Treating Follicular Lymphoma and Hope for ALS

  AI Therapeutics is a biotechnology company that uses artificial intelligence to match drugs to indications. They do so through the use of their algorithm, Guardian Angel. This algorithm has…

Continue Reading AI Therapeutics’ LAM-002 Shows Positive Results in Treating Follicular Lymphoma and Hope for ALS
A Patient and Scientist Join Forces to Spur Amyotrophic Lateral Sclerosis Research in Sweden
source: pixabay.com

A Patient and Scientist Join Forces to Spur Amyotrophic Lateral Sclerosis Research in Sweden

According to a story from ALS News Today, the nation of Sweden is starting to emerge as a leader for amyotrophic lateral sclerosis (ALS) research in Europe. This is mostly…

Continue Reading A Patient and Scientist Join Forces to Spur Amyotrophic Lateral Sclerosis Research in Sweden
Close Menu